Printer Friendly

Browse Dapagliflozin topic

Articles

1-65 out of 65 article(s)
Title Author Type Date Words
AstraZeneca reports approval in EU for Forxiga label update in type-2 diabetes. Aug 5, 2019 261
Forxiga label updated in the EU in type-2 diabetes. Aug 5, 2019 825
AstraZeneca reports approval in EU for Forxiga label update in type-2 diabetes. Aug 5, 2019 265
Supply Of Drugs. Jul 27, 2019 108
AstraZeneca provides update on decision by US FDA for Farxiga in type-1 diabetes. Jul 16, 2019 252
AstraZeneca provides update on decision by US FDA for Farxiga in type-1 diabetes. Jul 16, 2019 248
India,United States : Glenmark & Torrent sign licensing agreement for co-marketing of Remogliflozin Etabonate in India. Jul 15, 2019 409
India : Glenmark & Torrent sign licensing agreement for co-marketing of Remogliflozin Etabonate in India. Jul 11, 2019 408
Electronic Auction Among Small Businesses And Socially-oriented Non-profit Organizations For The Right To Conclude A Contract For The Supply Of Drugs (dapagliflozin) To Provide Citizens Eligible For State Social Assistance In Moscow (unz Z1915960). Jul 10, 2019 114
United Kingdom : Forxiga receives positive EU CHMP opinion for DECLARE-TIMI 58 cardiovascular outcomes data. Jul 5, 2019 207
AstraZeneca - Forxiga receives positive EU CHMP opinion for DECLARE-TIMI 58 cardiovascular outcomes data -- 1/7/2019. Jul 4, 2019 204
AstraZeneca reports recommendation of EU CHMP for Forxiga's marketing authorisation to include DECLARE-TIMI 58 CV outcomes data. Jul 2, 2019 327
AstraZeneca reports recommendation of EU CHMP for Forxiga's marketing authorisation to include DECLARE-TIMI 58 CV outcomes data. Jul 2, 2019 331
Iran Unveils 7 New Knowledge-Based Products. Jun 19, 2019 467
Iran Unveils 9 New Home-Made Hi-Tech Drugs. Jun 18, 2019 405
Farxiga Study Showed Reduced Progression of Kidney Disease or Renal Death in Patients with Type 2 Diabetes. Jun 11, 2019 136
Iran Boasts 3.3% Rise in Medicine Production. Jun 6, 2019 518
ADA Issues Updated Care Recommendations. Jun 3, 2019 597
Dapagliflozin's cardiac benefits bloom in T2D and prior MI. Jancin, Bruce Jun 1, 2019 958
SGLT2 inhibitors prevent HF hospitalization regardless of baseline LVEF. Jancin, Bruce Jun 1, 2019 404
HMC issues advisory on medications during Ramadan. May 20, 2019 1226
Purchase Of Dapagliflozin 10 Mg Tablet. May 19, 2019 110
Simultaneous Estimation of Saxagliptin and Dapagliflozin in Human Plasma by Validated High Performance Liquid Chromatography - Ultraviolet Method/Saksagliptin ve Dapagliflozin Tarafindan Dogrulanmis Yuksek Performansli Sivi Kromatografi - Ultraviyole Yontemi Insan Plazma Es Zamanli Tahmin. Donepudi, Sharmila; Achanta, Suneetha Report May 17, 2019 4686
Iran Industrializes Home-Made Drug to Treat Liver Cancer. May 12, 2019 390
Iran Vows to Indigenize Sanctioned Medicine. May 7, 2019 661
AstraZeneca - Qternmet XR approved in the US for the treatment of type-2 diabetes -- 3/5/2019. May 7, 2019 164
US Food and Drug Administration approves Qternmet XR. May 7, 2019 174
US Food and Drug Administration approves Qternmet XR. May 7, 2019 170
Iran Unveils 4 New Drugs for Treating Cancer, Diabetes. May 7, 2019 551
AstraZeneca's Qternmet XR approved by US FDA for type-2 diabetes. May 6, 2019 155
AstraZeneca's Qternmet XR approved by US FDA for type-2 diabetes. May 6, 2019 153
AstraZeneca's Qternmet XR approved by US FDA for type-2 diabetes. May 6, 2019 151
Iran Develops Know-How for Production of 4 Vital Cancer, Diabetes Drugs. May 6, 2019 427
Dapagliflozin beneficial in type 2 diabetes with prior Ml. Jancin, Bruce May 1, 2019 1063
Expert Opinion: Use of sodium glucose co-transporter type-2 inhibitors in South Asian population-The Pakistan perspective. Report Apr 30, 2019 6076
Diabetes Is a Major Risk Factor for Heart Disease: Lifestyle modifications can help protect your heart health. Mar 30, 2019 767
AstraZeneca's Forxiga receives approval in Japan for type-1 diabetes. Mar 28, 2019 353
AstraZeneca's Forxiga receives approval in Japan for type-1 diabetes. Mar 28, 2019 354
AstraZeneca's Forxiga receives approval in Japan for type-1 diabetes. Mar 28, 2019 349
European Commission approves AstraZeneca's Forxiga. Mar 27, 2019 214
European Commission approves AstraZeneca's Forxiga. Mar 27, 2019 210
ADA updates 2019 diabetes Standards of Care, adds recommendation on Vascepa. Mar 27, 2019 289
AstraZeneca's Forxiga approved in Europe for type-1 diabetes. Mar 26, 2019 382
AstraZeneca's Forxiga approved in Europe for type-1 diabetes. Mar 26, 2019 383
United Kingdom : Forxiga approved in Europe for type-1 diabetes. Mar 25, 2019 343
United Kingdom : First sub-analyses from the DECLARE-TIMI 58 trial further support the cardiovascular effects of Farxiga in type-2 diabetes. Mar 25, 2019 406
First Sub-Analyses from the DECLARE-TIMI 58 Trial Further Support the Cardiovascular Effects of Farxiga in Type 2 Diabetes. Mar 20, 2019 648
United Kingdom : AstraZeneca to present new cardiovascular data on Farxiga in type-2 diabetes at ACC 2019. Mar 18, 2019 211
Procurement Of Dapagliflozin 10mg For Dept Of Endocrine. Mar 14, 2019 146
US FDA expands approval of AstraZeneca's Farxiga and Xigduo XR. Mar 1, 2019 256
US FDA expands approval of AstraZeneca's Farxiga and Xigduo XR. Mar 1, 2019 252
SGLT2 INHIBITORS: Benefits in heart failure. Jancin, Bruce Mar 1, 2019 928
Managing glycaemic variability: Clinical approach. Report Feb 28, 2019 1657
SGLT2 inhibitors may increase the risk of serious adverse events. Drug overview Feb 28, 2019 692
US FDA Approves Expanded Farxiga and Xigduo XR Labels for Use in Patients with Type 2 Diabetes and Moderate Renal Impairment. Feb 28, 2019 214
AstraZeneca announces FDA approval for expanded FARXIGA, XIGDUO XR labels. Feb 27, 2019 233
Infeccion urinaria en pacientes con diabetes mellitus tipo 2: frecuencia, etiologia, susceptibilidad antimicrobiana y factores de riesgo. Lucas P., Elsa; Cristobal, Franco Q.; Castellano G., Maribel Jul 1, 2018 5865
Euglycemic Diabetic Ketoacidosis in the ICU: 3 Case Reports and Review of Literature. Lucero, Pablo; Chapela, Sebastian Jan 1, 2018 4500
Potent Oral Hypoglycemic Agents for Microvascular Complication: Sodium-Glucose Cotransporter 2 Inhibitors for Diabetic Retinopathy. Cho, Eun Hyung; Park, Se-Jun; Han, Seongwook; Song, Ji Hun; Lee, Kihwang; Chung, Yoo-Ri Jan 1, 2018 4574
Efficacy and Renal Safety of Dapagliflozin in Patients with Type 2 Diabetes Mellitus Also Receiving Metformin: A Real-Life Experience. Scorsone, Alessandro; Saura, Gabriella; Fleres, Mattia; Spano, Lucia; Aiello, Vito; Brancato, Davide Jan 1, 2018 3403
In Vitro Dissolution Profile of Dapagliflozin: Development, Method Validation, and Analysis of Commercial Tablets. de Meira, Rafaela Zielinski Cavalheiro; Maciel, Aline Biggi; Murakami, Fabio Seigi; de Oliveira, Pau Report Jan 1, 2017 3539
The SGLT-2 Inhibitor Dapagliflozin Has a Therapeutic Effect on Atherosclerosis in Diabetic [ApoE.sup.-/-] Mice. Leng, Weiling; Ouyang, Xinshou; Lei, Xiaotian; Wu, Mingxia; Chen, Liu; Wu, Qinan; Deng, Wuquan; Lian Report Jan 1, 2017 6375
Nice recommends new drug for some with type 2 diabetes. Brief article Jul 1, 2013 283
FDA rejects novel antidiabetes Drug, citing bladder and breast cancer risks. Tucker, Miriam E. Feb 1, 2012 1012
Bristol-Myers Squibb and AstraZeneca announce receipt of complete response letter from FDA for Dapagliflozin. Jan 20, 2012 196

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters